EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel approach to bilateral biliary drainage: EUS-guided hepaticoduodenodenostomy plus hepaticogastrostomy in malignant hilar biliary obstruction

Susumu Hijioka iD, Yoshikuni Nagashio, Yuta Maruki, Shota Harai, Daiki Agarie, Daiki Yamashige iD, Kohei Okamoto, Shin Yagi, Soma Fukuda iD, Yasuhiro Komori iD, Masaru Kuwada, Yutaka Saito und 1 weitere

Endoscopy International Open · 15.04.2025 · 13 (CP)

DOI: 10.1055/a-2565-8206 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 15.04.2025. Verfasst von Susumu Hijioka und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Chuo-ku, Japan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Cancer Center Research and Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biliary drainage for unresectable malignant hilar biliary obstruction (MHBO) can be technically challenging; therefore, there is a requirement for new treatment methods. This study evaluated the efficacy and safety of a novel bilateral drainage method—endoscopic ultrasound-guided hepaticoduodenostomy plus hepaticogastrostomy (EUS-HDGS)—which combines EUS-guided hepaticoduodenostomy (EUS-HDS) and hepaticogastrostomy (EUS-HGS). From 2018 to 2024, we reviewed eight cases of EUS-HDGS from 749 EUS procedures. Both EUS-HDS and EUS-HGS were performed simultaneously. The study outcomes were technical success, clinical success (reduced bilirubin levels or improved cholangitis within 14 days), and adverse events. Technical success was achieved in 87.5% cases (7/8), whereas clinical success was observed in 75.0% (6/8). Mild peritonitis occurred in 25% of patients (2/8) and 75.0% of patients (6/8) experienced recurrent biliary obstruction, with successful reintervention achieved in all cases. Median stent patency period was 90 days (95% confidence interval: 47.0–133). EUS-HDGS is a safe and effective drainage method for treating refractory MHBO and has potential as a viable treatment option.

Schlagwörter

Stichwörter der Autor:innen

Biliary tractEndoscopic ultrasonographyIntervention EUSPancreatobiliary (ERCP/PTCD)Strictures

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Chuo-ku, Japan.
  • Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.

ORCID-Profile: Susumu Hijioka, Daiki Yamashige, Soma Fukuda, Yasuhiro Komori

Förderung

  • The National Cancer Center Research and Development Fund

Zitieren

APA

Hijioka, S., Nagashio, Y., Maruki, Y., Harai, S., Agarie, D., Yamashige, D., Okamoto, K., Yagi, S., Fukuda, S., Komori, Y., Kuwada, M., Saito, Y., & Okusaka, T. (2025). Novel approach to bilateral biliary drainage: EUS-guided hepaticoduodenodenostomy plus hepaticogastrostomy in malignant hilar biliary obstruction. Endoscopy International Open, 13(CP). https://doi.org/10.1055/a-2565-8206

Vancouver

Hijioka S, Nagashio Y, Maruki Y, Harai S, Agarie D, Yamashige D, et al. Novel approach to bilateral biliary drainage: EUS-guided hepaticoduodenodenostomy plus hepaticogastrostomy in malignant hilar biliary obstruction. Endoscopy International Open. 2025;13(CP). doi:10.1055/a-2565-8206

BibTeX
@article{Hijioka2025,
  author = {Hijioka, Susumu and Nagashio, Yoshikuni and Maruki, Yuta and Harai, Shota and Agarie, Daiki and Yamashige, Daiki and Okamoto, Kohei and Yagi, Shin and Fukuda, Soma and Komori, Yasuhiro and Kuwada, Masaru and Saito, Yutaka and Okusaka, Takuji},
  title = {Novel approach to bilateral biliary drainage: EUS-guided hepaticoduodenodenostomy plus hepaticogastrostomy in malignant hilar biliary obstruction},
  journal = {Endoscopy International Open},
  year = {2025},
  volume = {13},
  number = {CP},
  doi = {10.1055/a-2565-8206}
}
Kostenlos starten →